MOEX: OZON - Ozon.ru

Yield per half year: +32.28%
Dividend yield: 0.00%
Sector: Ритейл

Company Analysis Ozon.ru

Download the report: word Word pdf PDF

1. Summary

Advantages

  • The stock's return over the last year (25.55%) is higher than the sector average (2.73%).
  • Current debt level 0% is below 100% and has decreased over 5 years from 15.44%.

Disadvantages

  • Price (4196.5 ₽) is higher than fair price (4051.21 ₽)
  • Dividends (0%) are below the sector average (11.43%).
  • The company's current efficiency (ROE=0%) is lower than the sector average (ROE=6.38%)

Similar companies

Лента

левенгук

Детский Мир

X5 Retail Group

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

Ozon.ru Ритейл Index
7 days 7.2% 4.6% 2.1%
90 days 41.4% 28.1% 33.5%
1 year 25.5% 2.7% 2.1%

OZON vs Sector: Ozon.ru has outperformed the "Ритейл" sector by 22.82% over the past year.

OZON vs Market: Ozon.ru has outperformed the market by 23.42% over the past year.

Stable price: OZON is not significantly more volatile than the rest of the market on "Московская биржа" over the last 3 months, with typical variations of +/- 5% per week.

Long period: OZON with weekly volatility of 0.4913% over the past year.

3. Summary of the report

3.1. General

P/E: -13
P/S: 1.91

3.2. Revenue

EPS -326.56
ROE 0%
ROA 0%
ROIC -46.19%
Ebitda margin 1.22%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (4196.5 ₽) is higher than the fair price (4051.21 ₽).

Price is higher than fair: The current price (4196.5 ₽) is 3.5% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (-13) is lower than that of the sector as a whole (6.71).

P/E vs Market: The company's P/E (-13) is lower than that of the market as a whole (9.19).

4.3. P/BV

P/BV vs Sector: The company's P/BV (0) is higher than that of the sector as a whole (-17.95).

P/BV vs Market: The company's P/BV (0) is lower than that of the market as a whole (10.07).

4.4. P/S

P/S vs Sector: The company's P/S indicator (1.91) is higher than that of the sector as a whole (0.6848).

P/S vs Market: The company's P/S indicator (1.91) is higher than that of the market as a whole (1.62).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (156.13) is higher than that of the sector as a whole (22.42).

EV/Ebitda vs Market: The company's EV/Ebitda (156.13) is higher than that of the market as a whole (-5.17).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Rising and has grown by 39.76% over the last 5 years.

Earnings Slowdown: The last year's return (0%) is below the 5-year average return (39.76%).

Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (204.63%).

5.4. ROE

ROE vs Sector: The company's ROE (0%) is lower than that of the sector as a whole (6.38%).

ROE vs Market: The company's ROE (0%) is lower than that of the market as a whole (67.91%).

5.5. ROA

ROA vs Sector: The company's ROA (0%) is lower than that of the sector as a whole (9.12%).

ROA vs Market: The company's ROA (0%) is lower than that of the market as a whole (17.3%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (-46.19%) is lower than that of the sector as a whole (11.7%).

ROIC vs Market: The company's ROIC (-46.19%) is lower than that of the market as a whole (16.32%).

6. Finance

6.1. Assets and debt

Debt level: (0%) is quite low in relation to assets.

Debt reduction: over 5 years, the debt has decreased from 15.44% to 0%.

Excess of debt: The debt is not covered by net income, percentage 0%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0% is below the average for the sector '11.43%.

7.2. Stability and increase in payments

Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.

Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

No insider transactions have been recorded yet

8.3. Main owners

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Ozon.ru

9.1. Stocks forum - Latest comments

30 december 14:51
а для ОзонФарма ветка есть ??

30 december 14:19
После одомашнивания 14К цена буд

28 december 09:57
Последний день для покупок. Планка?!

9.2. Latest Blogs

Yesterday at 14:04

Что интересного по рынку?


ВУШ наконец пробила 200 рублей и пошло ускорение: погода улучшается, самокаты выставят через неделю, до конца зимы осталось 4 дня.
217 ; 233 и зона продаж 264-277 сопротивления, объемы начинают заходить.
Увеличил позицию в стратегии и на личном счету, саму идею публиковал на прошлой неделе....


More

Yesterday at 11:36

📈 Российский рынок продолжает восходящий тренд: что ждать на новой неделе?

📊 Индекс МосБиржи стартовал в понедельник с продолжения пятничного роста. На открытии основной сессии он прибавил 0,8%, демонстрируя уверенный настрой инвесторов. #MOEX

🔹 Флагманы рынка – Сбербанк и Газпром – торгуются в плюсе, прибавляя в среднем 0,3%....


More

23 february 13:04

Привет 👋 Поздравляю всех с праздником днём защитника отечества! Желаю Всем всех благ и здоровья! Подготовил список предстоящих событий по бумагам нашего рынка на предстоящую торговую неделю в хронологическом порядке.

🤔 Как завтра отреагирует рынок на новые санкции от Великобритании? Увидим завтра) Гадать нет смысла. Думаю, что нас уже мало чем удивить... Но это рынок и всё может быть....


More


All blogs ⇨

9.3. Comments